May 15, 2018—A broad coalition of patient and consumer advocacy groups urged congressional leaders yesterday to join them “in supporting, not weakening, the 340B program.” The 61 groups made the appeal as Congress debates a variety of proposals to alter the program and on the eve of a Senate committee hearing this morning on the drug discount program. In their May 14 letter, … [Read more...]